Institutional Ownership C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC). We have compiled data on the 104 institutions that hold shares in the stock, with a total of 57.2 Million shares, which have been reported (via 13F filing form) to have a value of $128 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wasatch Advisors Inc
Salt Lake City, UT |
Aug 14, 2025 Q2 2025 |
7,424,662
shares
|
$16.6 Million
0.06% of portfolio
|
Q2 2025
Added 10.41%
|
|
Lynx1 Capital Management LP
San Juan, PR |
Aug 14, 2025 Q2 2025 |
7,098,133
shares
|
$15.9 Million
3.01% of portfolio
|
Q1 2025
Added 3.58%
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
6,978,942
shares
|
$15.6 Million
0.77% of portfolio
|
Q4 2024
Added 5.68%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
6,830,300
shares
|
$15.3 Million
0.35% of portfolio
|
Q1 2025
Added 56.02%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
4,754,188
shares
|
$10.6 Million
0.0% of portfolio
|
Q2 2025
Added 17.52%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,551,510
shares
|
$10.2 Million
0.0% of portfolio
|
Q2 2024
Added 402.93%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,018,022
shares
|
$6.76 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.47%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,008,004
shares
|
$4.5 Million
0.0% of portfolio
|
Q2 2025
Added 0.86%
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,111,910
shares
|
$2.49 Million
0.48% of portfolio
|
Q2 2024
Reduced 2.65%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,101,342
shares
|
$2.47 Million
0.0% of portfolio
|
Q2 2025
Added 1571.31%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,093,188
shares
|
$2.45 Million
0.0% of portfolio
|
Q2 2025
Added 409.64%
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
900,000
shares
|
$2.02 Million
0.08% of portfolio
|
Q4 2024
Added 28.57%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
880,258
shares
|
$1.97 Million
0.0% of portfolio
|
Q2 2025
Added 41.36%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
811,400
shares
|
$1.82 Million
0.0% of portfolio
|
Q2 2025
Added 1.35%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
745,053
shares
|
$1.67 Million
0.0% of portfolio
|
Q2 2025
Reduced 47.91%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
683,599
shares
|
$1.53 Million
0.0% of portfolio
|
Q2 2025
Added 32.84%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
572,026
shares
|
$1.28 Million
0.0% of portfolio
|
Q2 2025
Reduced 34.46%
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
492,612
shares
|
$1.1 Million
0.0% of portfolio
|
Q2 2025
Added 3816.77%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
441,735
shares
|
$989,486
0.0% of portfolio
|
Q2 2025
Reduced 36.68%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
431,888
shares
|
$967,429
0.0% of portfolio
|
Q2 2025
Reduced 16.0%
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
383,789
shares
|
$859,687
0.0% of portfolio
|
Q2 2025
Added 173.1%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
331,897
shares
|
$743,449
0.0% of portfolio
|
Q2 2025
Reduced 30.1%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
287,373
shares
|
$643,715
0.0% of portfolio
|
Q2 2025
Reduced 76.53%
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
239,959
shares
|
$537,508
0.0% of portfolio
|
Q2 2025
New holding
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
238,957
shares
|
$535,263
0.0% of portfolio
|
Q2 2025
Added 4193.93%
|